Urologic Oncology Research Program
Using basic science and translational research to improve clinical outcomes of patients with prostate, kidney and bladder cancers.
The Uro-Oncology research program holds extramural funding and engages in research collaborations to advance knowledge and clinical translation. Currently, the program is funded by a National Cancer Institute Program Project on "Prostate Cancer Bone Metastasis: Biology and Targeting," and NIH R01, Department of Defense and foundation research grants.
Collectively, we pursue strong inter- and intra-programmatic collaborations with three objectives:
- Understanding the "cross-talk" between the tumor and its microenvironment
- Developing new imaging, targeting and biomarkers
- Accelerating clinical translation of basic science discoveries from bench to bedside to improve the clinical outcome of patients with prostate, kidney and bladder cancers.
For information on diagnostic testing and screening, prostate cancer treatments or to find a physician, please visit the following Cedars-Sinai clinical programs: